Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,675.00    75.00 (1.63%)
Bid:
4,600.00
Ask:
4,750.00
Spread: 150.00 (3.261%)
Market Cap: £311.39m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Director/PDMR Shareholding

30 Jul 2025 07:00

RNS Number : 0866T
Judges Scientific PLC
30 July 2025
 

Judges Scientific plc

Director/PDMR Shareholding

Judges Scientific plc (AIM: JDG), a group focused on acquiring and developing companies in the scientific instrument sector announces that David Cicurel, Chief Executive Officer, and his spouse on 29 July 2025 effected a "Bed and ISA" by way of:

1. the sale of 310 ordinary shares of 5p each in the Company ("Ordinary Shares") by David Cicurel and immediate repurchase of the same number of Ordinary Shares, each at a price of 6425 pence per share, into David's ISA, and;

 

2. the sale of 315 Ordinary Shares by David Cicurel's spouse at a price of 6400 pence per share and immediate repurchase of the same number of Ordinary Shares at a price of 6410 pence per share, into her ISA.

Following this transaction David Cicurel's total beneficial and non-beneficial interest in Ordinary Shares remains unchanged. He is beneficially interested in 544,369 Ordinary Shares and beneficially and non beneficially interested in 611,369 Ordinary Shares, his non beneficial interest comprising 67,000 Ordinary Shares he has gifted to Shoftim Charitable Trust.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

David Cicurel

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Judges Scientific plc

b)

 

LEI

 

 

2138004EXWWPTW1JOL31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares in Judges Scientific plc

 

 

GB0032398678

 

b)

 

Nature of the transaction

 

 

Sale and repurchase of Ordinary Shares through a "Bed and ISA" arrangement

c)

 

Price(s) and volume(s)

 

 

 

Type

Price(s)

 

Volume(s)

Sale

6425p

 

310

 

Purchase

6425p

 

310

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

Type

Price(s)

 

Volume(s)

Sale & repurchase

6425p

 

310

 

 

 

e)

 

Date of the transaction

 

 

29/07/25

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Alejandra Cicurel

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Person Closely Associated with David Cicurel, Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Judges Scientific plc

b)

 

LEI

 

 

2138004EXWWPTW1JOL31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares in Judges Scientific plc

 

 

GB0032398678

 

b)

 

Nature of the transaction

 

 

Sale and repurchase of Ordinary Shares through a "Bed and ISA" arrangement

c)

 

Price(s) and volume(s)

 

 

 

Type

Price(s)

 

Volume(s)

Sale

6400p

 

315

 

Purchase

6410p

 

315

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

Type

Price(s)

 

Volume(s)

Sale

6400p

 

315

 

Purchase

6410p

 

315

 

 

 

e)

 

Date of the transaction

 

 

29/07/25

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

- Ends -  

 For further information please contact:

 

 

 

Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, CFO

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Joint Broker)

Stephane Auton

Harry Davies-Ball

Tel: +44 (0) 20 7408 4090

 

Liberum (Joint Broker)

Edward Mansfield

Nikhil Varghese

Josh Borlant

Tel : +44 (0) 20 3100 2222

 

 

Investec Bank plc (Joint Broker)

Virginia Bull

Carlton Nelson

Tel: +44 (0) 207 597 4000

Alma PR (Financial Public Relations)

Sam Modlin

Joe Pederzolli

Rebecca Sanders-Hewett

Sarah Peters

Tel: +44 (0) 20 3405 0205

judges@almapr.co.uk

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 25 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.

For further information, please visit www.judges.uk.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDBGDRDXDDGUC
Date   Source Headline
29th Sep 20097:00 amRNSHalf Yearly Report
22nd Sep 20097:00 amRNSNotice of Results
29th Jul 20093:53 pmRNSShare buyback programme
29th Jul 20099:45 amRNSDirector/PDMR Shareholding
28th Jul 20099:55 amRNSHolding(s) in Company
27th Jul 20097:00 amRNSDirector/PDMR Shareholding
24th Jul 20098:38 amRNSDirector/PDMR Shareholding
20th Jul 20097:00 amRNSTrading Statement
2nd Jul 20095:30 pmRNSHolding(s) in Company
18th Jun 200912:54 pmRNSFurther re Acquisition
10th Jun 20097:00 amRNSAcquisition
22nd May 20093:13 pmRNSAGM Statement
30th Apr 20091:54 pmRNSAnnual Financial Report
30th Mar 20097:00 amRNSFinal Results
30th Jan 20099:04 amRNSShare buyback programme
21st Jan 20097:00 amRNSTrading Statement
17th Dec 20082:46 pmRNSDirectorate Change
17th Nov 20087:00 amRNSAcquisition activity
26th Aug 20087:00 amRNSInterim Results
22nd Aug 200810:50 amRNSNotice of Results
15th Jul 20087:00 amRNSTrading Statement
13th Jun 20084:51 pmRNSHolding(s) in Company
13th Jun 20084:25 pmRNSHolding(s) in Company
13th Jun 20083:16 pmRNSHolding(s) in Company
9th Jun 20084:22 pmRNSFurther re Issue of Equity
22nd May 20087:00 amRNSAGM Statement
21st May 20087:00 amRNSIssue of Equity
29th Apr 20087:01 amRNSDirector/PDMR Shareholding
28th Apr 20085:28 pmRNSCirc re. Panel Waiver
28th Mar 20087:01 amRNSFinal Results
25th Mar 20087:01 amRNSFreehold property purchase
29th Jan 20087:00 amRNSPre Close Trading Statement
30th Nov 20077:01 amRNSDirector/PDMR Shareholding
27th Nov 20077:01 amRNSDirector/PDMR Shareholding
4th Oct 20077:01 amRNSDirector/PDMR Shareholding
25th Sep 20071:25 pmRNSGrant of Options/Dir holding
21st Sep 20077:02 amRNSInterim Results
9th Aug 20074:31 pmRNSHolding in Poole Investments
2nd Aug 20074:33 pmRNSCompany Website
21st May 20075:54 pmRNSResult of AGM
23rd Mar 20077:01 amRNSPreliminary Results
16th Mar 20077:00 amRNSNotice of Preliminary Results
9th Jan 20077:00 amRNSTrading Statement
21st Dec 20061:49 pmRNSTotal Voting Rights
7th Nov 20063:12 pmBUSRule 8.3 - Corus Group PLC
27th Oct 20062:29 pmBUSRule 8.3 - Corus Group PLC
26th Sep 20067:03 amRNSInterim Results
22nd Sep 20067:00 amRNSNotice of Results
5th Sep 20067:02 amRNSAcquisition
28th Mar 200612:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.